AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32

Authors: KOBAYASHI R WATANABE N IGUCHI A CHO Y YOSHIDA M ARIOKA H NAITO H SHIKANO T ISHIKAWA Y
Citation: R. Kobayashi et al., ELECTROENCEPHALOGRAM ABNORMALITY AND HIGH-DOSE BUSULFAN IN CONDITIONING REGIMENS FOR STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 21(3), 1998, pp. 217-220

Authors: FUKUMOTO H NISHIO M NISHIO K HEIKE Y ARIOKA H KUROKAWA H ISHIDA T FUKUOKA K NOMOTO T OHE Y SAIJO N
Citation: H. Fukumoto et al., INTERFERON-GAMMA-INDUCING FACTOR GENE TRANSFECTION INTO LEWIS-LUNG-CARCINOMA CELLS REDUCES TUMORIGENICITY IN-VIVO, Japanese journal of cancer research, 88(5), 1997, pp. 501-505

Authors: KUROKAWA H NISHIO K ISHIDA T ARIOKA H FUKUOKA K NOMOTO T FUKUMOTO H YOKOTE H SAIJO N
Citation: H. Kurokawa et al., EFFECT OF GLUTATHIONE DEPLETION ON CISPLATIN RESISTANCE IN CANCER-CELLS TRANSFECTED WITH THE GAMMA-GLUTAMYLCYSTEINE SYNTHETASE GENE, Japanese journal of cancer research, 88(2), 1997, pp. 108-110

Authors: OGASAWARA H NISHIO K ISHIDA T ARIOKA H FUKUOKA K SAIJO N
Citation: H. Ogasawara et al., IN-VITRO ENHANCEMENT OF ANTITUMOR-ACTIVITY OF A WATER-SOLUBLE DUOCARMYCIN DERIVATIVE, KW-2189, BY CAFFEINE-MEDIATED DNA-REPAIR INHIBITION IN HUMAN LUNG-CANCER CELLS, Japanese journal of cancer research, 88(11), 1997, pp. 1033-1037

Authors: FUKUOKA K ADACHI J NISHIO K ARIOKA H KUROKAWA H FUKUMOTO H ISHIDA T NOMOTO T YOKOTE H TOMONARI A NARITA N YOKOTA J SAIJO N
Citation: K. Fukuoka et al., P16(INK4) EXPRESSION IS ASSOCIATED WITH THE INCREASED SENSITIVITY OF HUMAN NONSMALL CELL LUNG-CANCER CELLS TO DNA TOPOISOMERASE-I INHIBITORS, Japanese journal of cancer research, 88(10), 1997, pp. 1009-1016

Authors: ARIOKA H NISHIO K HEIKE Y ABE S SAIJO N
Citation: H. Arioka et al., IN-VITRO AND IN-VIVO MODULATION BY RHIZOXIN OF NON-P-GLYCOPROTEIN-MEDIATED VINDESINE RESISTANCE, Journal of cancer research and clinical oncology, 123(4), 1997, pp. 195-200

Authors: ISHIDA T NISHIO K KUROKAWA H ARIOKA H FUKUMOTO H FUKUOKA K NOMOTO T YOKOTE H HASEGAWA S SAIJO N
Citation: T. Ishida et al., CIRCUMVENTION OF GLUTATHIONE-MEDIATED MITOMYCIN-C RESISTANCE BY A NOVEL MITOMYCIN-C ANALOG, KW-2149, International journal of cancer, 72(5), 1997, pp. 865-870

Authors: TOMONARI A NISHIO K KUROKAWA H ARIOKA H ISHIDA T FUKUMOTO H FUKUOKA K NOMOTO T IWAMOTO Y HIEKE Y ITAKURA M SAIJO N
Citation: A. Tomonari et al., IDENTIFICATION OF CIS-ACTING DNA ELEMENTS OF THE HUMAN GAMMA-GLUTAMYLCYSTEINE SYNTHETASE HEAVY SUBUNIT GENE, Biochemical and biophysical research communications, 232(2), 1997, pp. 522-527

Authors: FUKUDA M INOMATA M NISHIO K FUKUOKA K KANZAWA F ARIOKA H ISHIDA T FUKUMOTO H KUROKAWA H OKA M SAIJO N
Citation: M. Fukuda et al., A TOPOISOMERASE-II INHIBITOR, NK109, INDUCES DNA SINGLE-STRAND AND DOUBLE-STRAND BREAKS AND APOPTOSIS, Japanese journal of cancer research, 87(10), 1996, pp. 1086-1091

Authors: SAIJO N NISHIO K OHTA S ARIOKA H FUNAYAMA Y FUKUOKA K KUROKAWA H NOMOTO T ISHIDA T YAMAMOTO N TAMURA T SHINKAI T EGUCHI K OHE Y KUNITO H OHTSU T SASAKI Y
Citation: N. Saijo et al., PROGRESS IN PRECLINICAL AND CLINICAL-STUDIES FOR THE DEVELOPMENT OF NEW ANTICANCER DRUGS IN JAPAN, WITH EMPHASIS ON TAXANES, Cancer chemotherapy and pharmacology, 38, 1996, pp. 11-15

Authors: NISHIO K ISHIDA T ARIOKA H KUROKAWA H FUKUOKA K NOMOTO T FUKUMOTO H YOKOTE H SAIJO N
Citation: K. Nishio et al., ANTITUMOR EFFECTS OF BUTYROLACTONE-I, A SELECTIVE CDC2 KINASE INHIBITOR, ON HUMAN LUNG-CANCER CELL-LINES, Anticancer research, 16(6B), 1996, pp. 3387-3395

Authors: OHIRA T NISHIO K OHE Y ARIOKA H NISHIO M FUNAYAMA Y OGASAWARA H FUKUDA M YAZAWA K KATO H SAIJO N
Citation: T. Ohira et al., IMPROVEMENT BY EICOSANOIDS IN CANCER CACHEXIA INDUCED BY LLC-IL6 TRANSPLANTATION, Journal of cancer research and clinical oncology, 122(12), 1996, pp. 711-715

Authors: OHIRA T NISHIO K KANZAWA F ISHIDA T OHE Y ARIOKA H FUNAYAMA Y OGASAWARA H KATO H SAIJO N
Citation: T. Ohira et al., HYPERSENSITIVITY OF NIH3T3 CELLS TRANSFORMED BY H-RAS GENE TO DNA-TOPOISOMERASE-I INHIBITORS, International journal of cancer, 67(5), 1996, pp. 702-708

Authors: FUKUDA M NISHIO K KANZAWA F OGASAWARA H ISHIDA T ARIOKA H BOJANOWSKI K OKA M SAIJO N
Citation: M. Fukuda et al., SYNERGISM BETWEEN CISPLATIN AND TOPOISOMERASE-I INHIBITORS, NB-506 AND SN-38, IN HUMAN SMALL-CELL LUNG-CANCER CELLS, Cancer research, 56(4), 1996, pp. 789-793

Authors: OSHITA F ARIOKA H HEIKE Y SHIRAISHI J SAIJO N
Citation: F. Oshita et al., CORRELATION OF GENE-SPECIFIC DAMAGE WITH CISPLATIN BETWEEN HUMAN ADENOCARCINOMA CELLS AND PERIPHERAL-BLOOD MONONUCLEAR-CELLS ANALYZED BY POLYMERASE CHAIN REACTION-STOP ASSAY, Japanese journal of cancer research, 86(2), 1995, pp. 233-238

Authors: HEIKE Y TAKAHASHI M OHIRA T ARIOKA H FUNAYAMA Y NISHIO K OGASAWARA H SAIJO N
Citation: Y. Heike et al., IN-VIVO SCREENING MODELS OF CISPLATIN-RESISTANT HUMAN LUNG-CANCER CELL-LINES USING SCID MICE, Cancer chemotherapy and pharmacology, 35(3), 1995, pp. 200-204

Authors: ISHIKAWA Y KOBAYASHI R ARIOKA H CHO Y ITOH T
Citation: Y. Ishikawa et al., ALTERNATE-DAY CYCLOSPORINE-A TREATMENT FOR PATIENTS WITH APLASTIC-ANEMIA, Experimental hematology, 23(8), 1995, pp. 914-914

Authors: NAKASHIMA H LIEBERMAN R KARATO A ARIOKA H OHMATSU H NOMURA N SHIRAISHI J TAMURA T EGUCHI K SHINKAI T SASAKI Y YAMAMOTO N HUKUDA M OSHITA F OHE Y SAIJO N
Citation: H. Nakashima et al., EFFICIENT SAMPLING STRATEGIES FOR FORECASTING PHARMACOKINETIC PARAMETERS OF IRINOTECAN (CPT-11) - IMPLICATION FOR AREA UNDER THE CONCENTRATION-TIME CURVE MONITORING, Therapeutic drug monitoring, 17(3), 1995, pp. 221-229

Authors: NISHIO K ARIOKA H ISHIDA T FUKUMOTO H KUROKAWA H SATA M OHATA M SAIJO N
Citation: K. Nishio et al., ENHANCED INTERACTION BETWEEN TUBULIN AND MICROTUBULE-ASSOCIATED PROTEIN-2 VIA INHIBITION OF MAP KINASE AND CDC2 KINASE BY PACLITAXEL, International journal of cancer, 63(5), 1995, pp. 688-693

Authors: KUROKAWA H ISHIDA T NISHIO K ARIOKA H SATA M FUKUMOTO H MIURA M SAIJO N
Citation: H. Kurokawa et al., GAMMA-GLUTAMYLCYSTEINE SYNTHETASE GENE OVEREXPRESSION RESULTS IN INCREASED ACTIVITY OF THE ATP-DEPENDENT GLUTATHIONE S-CONJUGATE EXPORT PUMP AND CISPLATIN RESISTANCE, Biochemical and biophysical research communications, 216(1), 1995, pp. 258-264

Authors: SAIJO N NISHIO K TAKEDA Y ARIOKA H ISHIDA T NOMOTO T FUKUOKA K KUROKAWA H FUKUMOTO H
Citation: N. Saijo et al., PHORBOL ESTER AND OKADAIC ACID-RESISTANT CELLS - THE CROSSROADS OF SIGNAL-TRANSDUCTION AND DRUG-RESISTANCE, The American journal of medicine, 99, 1995, pp. 35-39

Authors: SHIKANO T ARIOKA H KOBAYASHI R NAITO H ISHIKAWA Y NAKADATE H HATAE Y TAKEDA T
Citation: T. Shikano et al., ACUTE LYMPHOBLASTIC-LEUKEMIA AND NON-HODGKINS-LYMPHOMA WITH MEDIASTINAL MASS - A STUDY OF 23 CHILDREN - DIFFERENT DISORDERS OR DIFFERENT STAGES, Leukemia & lymphoma, 13(1-2), 1994, pp. 161-167

Authors: OHIRA T OHE Y HEIKE Y PODACK ER OLSEN KJ NISHIO K NISHIO M MIYAHARA Y FUNAYAMA Y OGASAWARA H ARIOKA H KATO H SAIJO N
Citation: T. Ohira et al., GENE-THERAPY FOR LEWIS LUNG-CARCINOMA WITH TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-2 CDNAS CO-TRANSFECTED SUBLINE, Gene therapy, 1(4), 1994, pp. 269-275

Authors: YAMAMOTO N TAMURA T KARATO A UENAKA K EGUCHI K SHINKAI T OHE Y OSHITA F ARIOKA H NAKASHIMA H SHIRAISHI J FUKUDA M HIGUCHI S SAIJO N
Citation: N. Yamamoto et al., CPT-11 - POPULATION PHARMACOKINETIC MODEL AND ESTIMATION OF PHARMACOKINETICS USING THE BAYESIAN METHOD IN PATIENTS WITH LUNG-CANCER, Japanese journal of cancer research, 85(9), 1994, pp. 972-977

Authors: OHMATSU H EGUCHI K SHINKAI T TAMURA T OHE Y NISIO M KUNIKANE H ARIOKA H KARATO A NAKASHIMA H SASAKI Y TAJIMA K TADA N SAIJO N
Citation: H. Ohmatsu et al., A RANDOMIZED CROSS-OVER STUDY OF HIGH-DOSE METOCLOPRAMIDE PLUS DEXAMETHASONE VERSUS GRANISETRON PLUS DEXAMETHASONE IN PATIENTS RECEIVING CHEMOTHERAPY WITH HIGH-DOSE CISPLATIN, Japanese journal of cancer research, 85(11), 1994, pp. 1151-1158
Risultati: 1-25 | 26-32